Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

COVID-19 Caused Major Declines in Cancer Screenings and New Diagnoses

COVID-19 Caused Major Declines in Cancer Screenings and New Diagnoses

Cancer published a large-scale analysis on December 6, 2021. According to its findings, because of the COVID-19 pandemic, cancer screenings and new cancer diagnoses fell significantly. This means that some patients could not access cancer treatment and that advanced cancers increased.

In this article, we summarize the situation in the United States, England and Turkey.

Concerning Data from the United States

Using more than 9 million records, researchers reported that diagnoses of prostate, lung, bladder and colorectal (large bowel) cancers in 2020, compared with 2018 and 2019, showed a decline of 13–23%. Delays in cancer screenings and treatments were most pronounced early in the pandemic, when COVID-19 surges and lockdowns occurred across the United States.

According to the study's lead author, Brajesh Lal, these disruptions continued until late 2020.

Lal said, "We were all so focused on the impact of the (COVID-19) surge, infection and the resulting loss of life that we naturally and appropriately mobilized all our resources to prevent it. What surprised me was that this growing decline in healthcare services continued. We still have not recovered."

England Is Facing Its Biggest Cancer Crisis Ever

The United States is not the only country affected. Recent reports from the United Kingdom emphasized that the pandemic seriously disrupted cancer screenings, early diagnosis and even cancer treatments.

A report on patient backlogs and waiting times prepared by the United Kingdom’s National Audit Office stated that the estimated number of "missing" urgent referrals for suspected cancer during the pandemic reached as many as 740,000, and that between 35,000 and 60,000 patients with cancer had missed their first treatment since the pandemic began.

A Healthcare System Operating at Maximum Capacity

The COVID pandemic caused a sharp increase in waiting times and waiting times in a healthcare system operating very close to its maximum capacity.

In the United States, by September 2021, 5.83 million patients were on the waiting list for elective care (nonemergency medical treatments); 1.95 million of them had been waiting longer than 18 weeks and 301,000 had been waiting for more than a year.

Brajesh Lal and his colleagues began this study to better understand how the pandemic affected cancer screenings and diagnostic procedures, and consequently new cancer diagnoses, by examining data on millions of patients from the Veterans Health Administration, the largest integrated dataset in the United States.

Using 2018 – 2019 cancer-related healthcare encounters, cancer screenings and diagnoses as a baseline, the researchers calculated pandemic-related changes in diagnostic and screening procedures and new prostate, lung, bladder and colorectal cancer diagnoses in 2020.

The declines in diagnoses were as follows:

  1. Colonoscopy – 46%
  2. Prostate biopsies– 29%
  3. Cystoscopies for bladder cancer – 21%
  4. CT scans for lung cancer – 12%

The researchers reported that these declines varied between regions within the country, but that “there was no consistent pattern by geographical region or state” . For example, in two-thirds of states, prostate biopsies declined by more than 25% in 2020 compared with 2018 and 2019, and the remainder showed a similar decline in cystoscopies. New cancer diagnoses also fell significantly in 2020, with the greatest decline occurring in the first few months of the pandemic. For example, between March and May, prostate cancer diagnoses fell by more than 50%. The researchers said there were “similar rates of decline” in new colorectal, lung and bladder cancer diagnoses.

Although new cancer diagnoses began to rise from June 2020 onward, they never reached prepandemic levels. The researchers say that, as a result, the shortfall in new cancer diagnoses compared with the past persisted throughout 2020.

The declines in new cancer diagnoses that the researchers expected throughout 2020 compared with 2018 and 2019 were as follows:

  • Prostate cancer: 23%
  • Colorectal cancer: 20%
  • Bladder cancer: 18%
  • Lung cancer: 13%

Several reasons for the decline in diagnoses were highlighted:

  • Pandemic-related financial difficulties
  • The risks of invasive procedures such as colonoscopy
  • Patients unable to follow routine health programs

Lal also says that pandemic-related resource shortages, including a shortage of nurses and hospital closures, may have prevented a return to normal. In addition, the research team plans to analyze the long-term health effects of these delays in cancer diagnoses.

Some reports have already begun highlighting the consequences of delayed cancer diagnoses. For example, a survey by the American Society for Radiation Oncology published in March 2021 reported that two-thirds of physicians said cancers in newly diagnosed patients were at more advanced stages in early 2021 than before the pandemic. Lal says, “We will see the full impact of the pandemic on early cancer diagnosis 2, 5, 10 years from now.”

What Is the Situation in Turkey?

We know that many people in Turkey also hesitated to go to healthcare centers early in the pandemic and put off cancer screenings. However, there is no backlog or healthcare system blockage in Turkey due to postponed screenings. Anyone who wishes can currently have free age-appropriate cancer screenings through KETEMs (Cancer Early Diagnosis, Screening and Education Centers); they can also obtain cancer screening/diagnostic services appropriate to their age or symptoms from public and private hospitals.

We can readily say that in Turkey, COVID-19 caused far fewer disruptions to cancer treatments than in Europe and the United States. In fact, Turkey's oncology system has the capacity to relieve the pandemic-related congestion in European oncology services through health tourism.

*

Sources

COVID Has Led to Big Declines in Cancer Screenings, New Diagnoses - Medscape - Dec 06, 2021.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

COVID-19 Caused Major Declines in Cancer Screenings and New Diagnoses

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy